Colgate-Palmolive Company $CL Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. lowered its position in shares of Colgate-Palmolive Company (NYSE:CL) by 1.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 956,785 shares of the company’s stock after selling 10,616 shares during the period. Principal Financial Group Inc.’s holdings in Colgate-Palmolive were worth $76,485,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC increased its stake in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares during the period. Woodline Partners LP increased its position in Colgate-Palmolive by 76.3% in the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after acquiring an additional 20,062 shares during the period. Ameritas Advisory Services LLC increased its position in Colgate-Palmolive by 22.9% in the 2nd quarter. Ameritas Advisory Services LLC now owns 3,059 shares of the company’s stock valued at $278,000 after acquiring an additional 570 shares during the period. Grimes & Company Inc. boosted its position in Colgate-Palmolive by 1.0% during the 2nd quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock worth $1,136,000 after acquiring an additional 118 shares during the period. Finally, Relyea Zuckerberg Hanson LLC grew its stake in shares of Colgate-Palmolive by 3.9% in the second quarter. Relyea Zuckerberg Hanson LLC now owns 3,833 shares of the company’s stock worth $348,000 after purchasing an additional 143 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Trending Headlines about Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Company reported stronger-than-expected Q4 results (EPS beat and revenue above consensus), boosting confidence in near-term growth and prompting analyst forecast lifts. Colgate-Palmolive Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results
• Positive Sentiment: JPMorgan raised its price target to $97 and kept an “overweight” stance, signaling projected upside and institutional confidence. JPMorgan target raise (Benzinga)
• Positive Sentiment: Bank of America and Evercore ISI lifted targets to $100 (Bank of America) and $100 (Evercore) with buy/outperform views — these upgrades support further upside expectations. Bank of America & Evercore coverage (Benzinga / TickerReport)
• Positive Sentiment: Zacks highlighted CL as a strong growth stock using its Style Scores, adding a retail-oriented, research-backed positive narrative for growth investors. Here’s Why Colgate-Palmolive (CL) is a Strong Growth Stock
• Positive Sentiment: TD Cowen / TipRanks coverage reiterated a bullish thesis around premiumization and the company’s 2030 strategic plan, supporting longer-term confidence among buy-side analysts. TD Cowen: Strengthening earnings visibility and long-term growth
• Neutral Sentiment: Fortune ran a piece on Colgate’s talent rotations and leadership development — positive for long-term culture and management depth but unlikely to move near-term stock price materially. Why Colgate-Palmolive is moving talent across borders to develop leaders
• Negative Sentiment: Deutsche Bank and Jefferies maintained/issued hold ratings with price targets below or near the current level (Deutsche DB raised to $90; Jefferies to $91), which could limit upside or encourage some profit-taking. Deutsche Bank & Jefferies coverage (Benzinga / TickerReport)

Colgate-Palmolive Price Performance

NYSE CL opened at $93.08 on Wednesday. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $100.18. The business’s fifty day moving average is $81.28 and its two-hundred day moving average is $81.41. The stock has a market capitalization of $75.03 billion, a P/E ratio of 35.53, a P/E/G ratio of 6.18 and a beta of 0.29. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.91 EPS. On average, research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.2%. The ex-dividend date is Wednesday, January 21st. Colgate-Palmolive’s payout ratio is presently 79.39%.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CL. Morgan Stanley lifted their price objective on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a research note on Monday. Argus restated a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Bank of America upped their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday. Piper Sandler raised their price objective on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the company an “overweight” rating in a research note on Friday. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a research report on Monday. Eleven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $94.47.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.